Whereas the inhibition of MAO has modest, but significant effect in slowing down progression of Parkinson’s disease, it may be useful to mimic the protective function of parkin using inhibitors of estrogen-related receptors [125,141,143]. Here, PRKN is linked to Parkinson disease.